Increased PD-L1 expression on tumor cells was noted on BRCA-1 mutated cancers only, and this difference may be related to an increased frequency of loss of PTEN function in BRCA-1 as compared to BRCA-2 [28]. This evidence concerns the gene CD274 and cancer.